SNAP25 and Alzheimer disease: The study of Sutphen et al, found that the expression of SNAP-25 was decreased in the brain tissue of AD patients, but it was highly expressed in the cerebrospinal fluid, and was highly positively correlated with the injury degree of AD.[29] This phenomenon exists in the early stage of AD and gradually progresses with the prolongation of the disease course.